International Conference on HIV and Drug Resistance Studies (ICHDRS-26)

About the event

*Latest advances in HIV treatment, prevention, and drug resistance research. *Mechanisms and causes of HIV drug resistance and factors contributing to treatment failure. *Current approaches to antiretroviral therapy (ART) and treatment optimization. *Emerging resistance patterns, including resistance to integrase inhibitors such as dolutegravir. *HIV drug resistance testing, genotyping, sequencing, and laboratory methods. *The role of viral load monitoring in detecting treatment failure and preventing resistance. *Strategies for HIV drug-resistance surveillance at clinical and population levels. *Management of patients with virologic failure and resistant HIV strains. *Prevention and management of resistance associated with PrEP and other HIV prevention strategies. *Advances in next-generation sequencing and molecular technologies for HIV resistance research. *New and emerging antiretroviral drugs, long-acting therapies, and treatment strategies. *Approaches to improving adherence, treatment retention, and sustained viral suppression. *Current research, clinical evidence, and emerging innovations in HIV drug resistance. *Public-health strategies to prevent, monitor, and respond to HIV drug resistance, including strengthening laboratory capacity and surveillance systems. *Opportunities to exchange knowledge with international researchers, clinicians, laboratory specialists, and public-health experts.